Strict peptide length is not required for the induction of cytotoxic T lymphocyte‐mediated antiviral protection by peptide vaccination

Sendai virus nuclear protein peptides of different lengths were titrated in peptide vaccination experiments. We observed that peptide length was not important in inducing cytotoxic T lymphocyte‐mediated protective immunity in vivo against a challenge with a lethal dose of virus. These results suggest that long peptides are trimmed in vivo to peptides that fit into the groove of major histocompatibility complex class I molecules. In addition several adjuvants were screened for their effectiveness in peptide vaccination protocols. Incomplete Freund's adjuvant and Titermax™ turned out to be useful, whereas alum was much less effective.

[1]  P. A. Peterson,et al.  Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb. , 1994, Science.

[2]  T. Schumacher,et al.  Mechanisms of induction of primary virus‐specific cytotoxic T lymphocyte responses , 1992, European journal of immunology.

[3]  P. A. Peterson,et al.  Emerging principles for the recognition of peptide antigens by MHC class I molecules. , 1992, Science.

[4]  R. Henderson,et al.  Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. , 1992, Science.

[5]  L. Ährlund‐Richter,et al.  Immunization against polyoma tumors with synthetic peptides derived from the sequences of middle‐and large‐T antigens , 1992, International journal of cancer.

[6]  C. Leclerc,et al.  In vivo induction of cytotoxic T cell response by a free synthetic peptide requires CD4+ T cell help. , 1991, Journal of immunology.

[7]  T. Schumacher,et al.  Peptide loading of empty major histocompatibility complex molecules on RMA‐S cells allows the induction of primary cytotoxic T lymphocyte responses , 1991, European journal of immunology.

[8]  F. Liew,et al.  Priming of influenza virus-specific cytotoxic T lymphocytes vivo by short synthetic peptides. , 1991, Journal of immunology.

[9]  H. Schild,et al.  Efficiency of peptides and lipopeptides for in vivo priming of virus‐specific cytotoxic T cells , 1991, European journal of immunology.

[10]  W. Kast,et al.  In vivo efficacy of virus-derived peptides and virus-specific cytotoxic T lymphocytes. , 1991, Immunology letters.

[11]  D. R. Madden,et al.  Identification of self peptides bound to purified HLA-B27 , 1991, Nature.

[12]  H. Rammensee,et al.  Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.

[13]  Hidde L. Ploegh,et al.  Peptide selection by MHC class I molecules , 1991, Nature.

[14]  W. Kast,et al.  Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[15]  R. Zinkernagel,et al.  Peptide-induced antiviral protection by cytotoxic T cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[16]  S. Nathenson,et al.  Isolation of an endogenously processed immunodominant viral peptide from the class I H–2Kb molecule , 1990, Nature.

[17]  J. Whitton,et al.  Vaccination and protection from a lethal viral infection: identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope. , 1990, Virology.

[18]  W. Kast,et al.  Treatment with monoclonal anti-CD3 antibody protects against lethal Sendai virus infection by induction of natural killer cells. , 1990, Journal of Immunology.

[19]  Hidde L. Ploegh,et al.  Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro , 1990, Cell.

[20]  H. Rammensee,et al.  In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine , 1989, Nature.

[21]  R. Offringa,et al.  Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes , 1989, Cell.

[22]  J. Whitton,et al.  Fine dissection of a nine amino acid glycoprotein epitope, a major determinant recognized by lymphocytic choriomeningitis virus-specific class I-restricted H-2Db cytotoxic T lymphocytes , 1988, The Journal of experimental medicine.

[23]  W. Kast,et al.  Cooperation between cytotoxic and helper T lymphocytes in protection against lethal Sendai virus infection. Protection by T cells is MHC- restricted and MHC-regulated; a model for MHC-disease associations , 1986, The Journal of experimental medicine.

[24]  A. McMichael,et al.  The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides , 1986, Cell.

[25]  R. Hodges,et al.  Monitoring of solid phase peptide synthesis by an automated spectrophotometric picrate method. , 1975, Analytical biochemistry.